Coondoo A, Chattopadhyay C. Drug interactions in dermatology: What the dermatologist should know. Indian J Dermatol 2013;58:249-54.
In the Abstract co- application of topical corticosteroids and aloe vera should be read as a drug – drug interaction instead of as a drug - disease interaction.
In Table 4, The first word of the first point under the heading ‘effects’ in Table 4, should be read as ‘decreased’ rather than ‘increased’ –
In Table 6, under the heading Effect read all cotrticosteroids in place of methylprednisolone with respect to drug-drug interaction of corticosteroid with Ketoconazole and Itraconazole.
In Table 6 reference to the statement that occurrence of hypoglycemia due to a combination of corticosteroids and antidiabetic medications has not been mentioned in the article due to oversight. The reference to be quoted is Gillam M. Drug interactions with oral hypoglycaemic drugs. Aust Prescr 2001;24:83.
In Table 6, under the heading Effects please read ‘decreased’ in place of ‘increased’ with reference to reaction between antifungals (Ketoconazole) and Rifampicin.
In Table 6, reference for the statement that a combination of methotrexate and corticosteroids leads to an increased risk of hepatotoxicity has not been mentioned in References due to oversight. The reference to be quoted is: Lafforgue P, Monjanel-Mouterde S, Durand A, Catalin J, Acquaviva PC Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients. J Rheumatol. 1993 Feb;20(2):263-7.
In Table 7 the co-prescription of PUVA and NBUVB with Calcipotriol has been erroneously mentioned as agonistic and should be deleted from the Table.
These errors are regretted.
-Editor, IJD®